INTRODUCTION
Although the need for continuous monitoring of Glaucoma patients is recognized by researchers and clinicians in the field, no method is so far available [4], [5]. Glaucoma is a widespread disease with intraocular pressure (IOP) as the main risk factor. According to the World Health Organization (WHO) estimates, there are 67 million people with Glaucoma worldwide and in the industrialized world, patients receiving treatment are some 5 million. Their treatment could be optimized (and costs reduced) with improved diagnostic tools. Detailed knowledge of IOP behavior in Glaucoma patients is of paramount importance for the understanding and the prognosis of the disease evolution as increased IOP is known to cause optic nerve degeneration.